Similarly, in lung cancer, cytokines have a significant impact on cancer prognosis, such as the upregulation of IL-17A in the lung tumor-induced overexpression of NLRP3 and the enhanced lung tumor invasiveness ability mediated by the EMT [67]. This evidence concerns the gene IL17A and lung carcinoma.